Related Experiment Videos
Radiation therapy for a rising PSA level after radical prostatectomy
R Tiguert1, J D Forman, M Hussain
1Department of Urology, Wayne State University School of Medicine, and the Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, USA.
Seminars in Urologic Oncology
|August 26, 1999
Summary
Salvage radiation therapy can effectively control local recurrence in men with rising prostate-specific antigen (PSA) levels after prostatectomy. Optimal candidates have a PSA level below 2 ng/mL and no palpable recurrence.
Area of Science:
- Urology
- Radiation Oncology
Background:
- Radical prostatectomy is increasingly common in asymptomatic men due to routine prostate-specific antigen (PSA) testing.
- A significant percentage (30%-40%) of patients experience recurrence after prostatectomy, necessitating effective treatment options.
Purpose of the Study:
- To evaluate the role and effectiveness of salvage radiation therapy in managing recurrent prostate cancer after radical prostatectomy.
- To identify optimal candidates for salvage radiotherapy based on clinical and biochemical parameters.
Main Methods:
- Review of existing literature and clinical data on salvage radiotherapy for post-prostatectomy recurrence.
- Analysis of patient outcomes, focusing on disease-free survival and local recurrence control.
Main Results:
- Salvage radiation therapy demonstrates promise in controlling local recurrence for men with rising PSA levels.
- Disease-free survival impact is encouraging, though specific therapeutic guidelines are still developing.
Conclusions:
- Salvage radiotherapy is an effective strategy for managing local recurrence in the setting of rising PSA post-prostatectomy.
- Ideal candidates for this therapy include those with a serum PSA level under 2 ng/mL, no palpable recurrence, and preserved urinary continence.